Novo Nordisk Offering Large Discount on Wegovy in Bid to Recapture Market

Novo Nordisk Offering Large Discount on Wegovy in Bid to Recapture Market

It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy. Competitors are nipping at its heels, cheaper knockoffs have been eating into its sales, and it just gave the boot to its former CEO. Now, hoping its worst days are behind it, Novo says it's offering customers a massive discount on Wegovy, the weight-loss variant of its flagship drug semaglutide. For your first month of treatment…

More than three quarters of the patients taking both drugs reported at least one side effect, mainly mild or moderate gastrointestinal problems such as nausea, constipation, diarrhoea and vomiting.

Inside 'potentially catastrophic' fat jab crisis that is shrinking Brits

FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it turns out that number on the scales might not be the only thing shrinking. GettyWeight loss injections could be increasing the risk of agonising fractures and leaving people facing a lifetime plagued by an ‘old-lady bone disease’[/caption] Sophie WrightSophie Wright, 35, has suffered from osteoporosis[/caption] Sophie Wright‘…

The summer invites many to initiate changes in their diet and lifestyle. Some do so for aesthetics, others for health. For Sanne Christensen, it was a matter of survival. At just 41 years old, this Danish woman dragged a kidney disease and suffered constant mobility problems due to her weight. In a single year, she had to be hospitalized six times. The turning point came when she confessed to her psychologist that she wished not to wake up. Walk…

A medical investigation found a biologically active natural peptide that equals the power of Ozempic but with fewer side effects